DUBLIN–(BUSINESS WIRE)–The “Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech) – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s providing.
The worldwide leukapheresis market is projected to succeed in USD 98 Million by 2027 from USD 65 Million in 2022, at a CAGR of 8.5%. The worldwide leukopaks market is projected to succeed in USD 784 Million by 2027 from USD 146 Million in 2022, at a CAGR of 39.8%. As a result of circumstances of leukaemia rising globally, and the rising want for leukopaks in medical trials and different analysis purposes, the leukapheresis market is predicted to develop within the forecast interval.
By software, analysis purposes was the bigger section within the leukapheresis merchandise market in 2021.
By, software, the leukapheresis market is segmented into analysis purposes and therapeutic purposes. The analysis purposes section accounted for the bigger share of the leukapheresis merchandise market in 2021. The rising improvement of cell-based immunotherapies and rising demand for leukapheresis-derived major cells in drug improvement are a number of the main components driving the expansion of the leukapheresis merchandise market throughout the forecast interval.
Amongst finish customers, the educational & analysis institutes section accounted for the most important share of the leukopaks market in 2021.
By finish consumer, the leukopaks market is segmented into educational & analysis institutes, pharmaceutical & biotechnology firms, and contract analysis organizations. In 2021, the educational & analysis institutes section accounted for the most important share of the leukapheresis merchandise market. The rising variety of industry-academic partnerships for conducting analysis on cell-based most cancers therapies are driving the expansion of this end-user section.
In 2021, North America accounted for the most important regional marketplace for leukopaks market
This may be attributed to the presence of a lot of leukopak manufacturing firms within the area, and straightforward accessibility to technologically superior blood separation units, amongst different components. The Asia Pacific area is predicted to be the fastest-growing area within the forecast interval. The rising CAR-T cell remedy analysis and the rising variety of pharma & biotech firms and analysis institutes in China are a number of the components driving the market development.
Market Dynamics
Drivers
- Rising Incidence and Prevalence of Leukemia
- Growing Variety of Blood Donations
- Elevated Demand for Leukopaks in Medical Analysis
Restraints
- Excessive Price of Therapeutic Leukapheresis and Leukopaks
- Stringent Donor Recruitment Standards
- Dearth of Expert Professionals and Low Adoption of Therapeutic Leukapheresis
- Problems Related to Therapeutic Leukapheresis
- Lengthy Procedural Time for Leukapheresis
- Excessive Price of Mobile Immunotherapies and Lack of Favorable Reimbursement
Alternatives
- Leukapheresis for Pediatric Sufferers
- Rising Economies with Investments from Tutorial Institutes, Pharma-Biotech Firms, and Main Gamers
- Gaps in Present Leukapheresis Applied sciences
Challenges
- Blood Transfusion Security in Rising Nations
Key Matters Coated:
1 Introduction
2 Analysis Methodology
3 Govt Abstract
4 Premium Insights
5 Market Overview
6 Leukapheresis Merchandise Market, by Sort
7 Leukapheresis Merchandise Market, by Software
8 Leukapheresis Merchandise Market, by Finish-user
9 Leukopaks Market, by Sort
10 Leukopaks Market, by Indication
11 Leukopaks Market, by Finish-user
12 Leukapheresis Market, by Area
13 Aggressive Panorama
14 Firm Profiles
15 Appendix
Firms Talked about
- Accegen
- Asahi Kasei Company
- Beijing Zksk Expertise Co. Ltd.
- Bioivt
- Caltag Medsystems Restricted
- Charles River Laboratories Worldwide, Inc.
- Discovery Life Sciences, Inc.
- First Alternative Bio LLC
- Fresenius SE & Co. KGaA
- Guangzhou Daji Medical Science and Expertise Co. Ltd.
- Haemonetics Company
- Clever Tissue Group
- Lonza Group AG
- Macopharma SA
- Medica Spa.
- Miltenyi Biotec
- Nikkiso Co. Ltd.
- Pall Company
- Precision for Drugs, Inc.
- Puriblood Medical Co. Ltd.
- Sb-Kawasumi Laboratories, Inc.
- Stemexpress, LLC
- Terumo BCT
- Trina Bioreactives AG
- Zenbio, Inc.
For extra details about this report go to https://www.researchandmarkets.com/r/bn1u6j
from Academic Summaries – My Blog https://ift.tt/gIHZ4Jp
via IFTTT
No comments:
Post a Comment